SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-053957
Filing Date
2021-11-03
Accepted
2021-11-03 16:11:23
Documents
65
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bmea-10q_20210930.htm   iXBRL 10-Q 2601734
2 EX-31.1 bmea-ex311_8.htm EX-31.1 20082
3 EX-31.2 bmea-ex312_10.htm EX-31.2 20096
4 EX-32.1 bmea-ex321_7.htm EX-32.1 9094
5 EX-32.2 bmea-ex322_6.htm EX-32.2 9111
  Complete submission text file 0001564590-21-053957.txt   7511130

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bmea-20210930.xsd EX-101.SCH 42207
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bmea-20210930_cal.xml EX-101.CAL 43295
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmea-20210930_def.xml EX-101.DEF 152110
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmea-20210930_lab.xml EX-101.LAB 360372
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmea-20210930_pre.xml EX-101.PRE 281126
11 EXTRACTED XBRL INSTANCE DOCUMENT bmea-10q_20210930_htm.xml XML 1068818
Mailing Address 650 MAIN STREET REDWOOD CITY CA 94063
Business Address 650 MAIN STREET REDWOOD CITY CA 94063 (650) 980-9099
Biomea Fusion, Inc. (Filer) CIK: 0001840439 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40335 | Film No.: 211375465
SIC: 2834 Pharmaceutical Preparations